XML 53 R25.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue (Tables)
 12 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
Reserves for sales returns consist of the following (in thousands):
Years ended June 30,
20242023
Beginning balance$129 $131 
Additions1,622 1,978 
Returns(1,618)(1,980)
Ending balance$133 $129 
The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):
 Years ended June 30,
 20242023
Americas$152,907 $155,361 
Asia/Pacific & Europe47,257 58,037 
Total revenue$200,164 $213,398 
Additional information as to the Company’s revenue from operations in the most significant geographical areas is set forth below (in thousands):
 Years ended June 30,
 20242023
United States$145,679 $148,522 
Japan$26,989 $32,082 
Schedule of Revenues by Major Product Line The following table shows revenue by major product line for the fiscal years ended June 30, 2024 and 2023:
Years ended June 30,
20242023
Protandim® product line
$104,135 52.0 %$119,720 56.1 %
TrueScience® product line
56,252 28.1 %49,494 23.2 %
Other39,777 19.9 %44,184 20.7 %
Total$200,164 100.0 %$213,398 100.0 %